Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.

@article{Bang2016PredictingDP,
  title={Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.},
  author={Jee A Bang and Iryna Lobach and Anthony E Lang and Murray Grossman and David S. Knopman and Bruce L. Miller and L. S. Schneider and Rachelle Doody and A. J. Lees and Michael Gold and Bruce H. Morimoto and Adam L. Boxer},
  journal={Parkinsonism & related disorders},
  year={2016},
  volume={28},
  pages={41-48}
}
INTRODUCTION Clinical and MRI measurements can track disease progression in PSP, but many have not been extensively evaluated in multicenter clinical trials. We identified optimal measures to capture clinical decline and predict disease progression in multicenter PSP trials. METHODS Longitudinal clinical rating scales, neuropsychological test scores, and… CONTINUE READING